Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 3

See more details

Referenced in 1 policy sources
18 readers on Mendeley
  • Article usage
  • Citations to this article (46)

Advertisement

Research Article Free access | 10.1172/JCI112520

Metabolic reduction of chromium by alveolar macrophages and its relationships to cigarette smoke.

F L Petrilli, G A Rossi, A Camoirano, M Romano, D Serra, C Bennicelli, A De Flora, and S De Flora

Find articles by Petrilli, F. in: JCI | PubMed | Google Scholar

Find articles by Rossi, G. in: JCI | PubMed | Google Scholar

Find articles by Camoirano, A. in: JCI | PubMed | Google Scholar

Find articles by Romano, M. in: JCI | PubMed | Google Scholar

Find articles by Serra, D. in: JCI | PubMed | Google Scholar

Find articles by Bennicelli, C. in: JCI | PubMed | Google Scholar

Find articles by De Flora, A. in: JCI | PubMed | Google Scholar

Find articles by De Flora, S. in: JCI | PubMed | Google Scholar

Published June 1, 1986 - More info

Published in Volume 77, Issue 6 on June 1, 1986
J Clin Invest. 1986;77(6):1917–1924. https://doi.org/10.1172/JCI112520.
© 1986 The American Society for Clinical Investigation
Published June 1, 1986 - Version history
View PDF
Abstract

Pulmonary alveolar macrophages (PAM), obtained by bronchoalveolar lavage from 47 individuals, reduced hexavalent chromium [Cr(VI)] and decreased its mutagenicity. Their specific activity--mostly mediated by cytosolic, enzyme-catalyzed mechanisms--was significantly higher than in corresponding preparations of mixed-cell populations from human peripheral lung parenchyma or bronchial tree, or from rat lung or liver. At equivalent number of PAM, Cr(VI) reduction, total protein, and some oxidoreductase activities were significantly increased in smokers. No appreciable variation could be detected between lung cancer and noncancer patients. In rats, the Cr(VI)-reducing activity of PAM preparations was induced by Aroclor 1254. Thus, alveolar macrophages provide crucial defense mechanisms not only by phagocytizing metals, but also by metabolically reducing Cr(VI). The epithelial-lining fluid (ELF) also displayed some Cr(VI) reduction. Together with already investigated metabolic processes occurring inside lung cells, these mechanisms are expected to determine thresholds in the pulmonary carcinogenicity of chromium.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1917
page 1917
icon of scanned page 1918
page 1918
icon of scanned page 1919
page 1919
icon of scanned page 1920
page 1920
icon of scanned page 1921
page 1921
icon of scanned page 1922
page 1922
icon of scanned page 1923
page 1923
icon of scanned page 1924
page 1924
Version history
  • Version 1 (June 1, 1986): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 3
  • Article usage
  • Citations to this article (46)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
18 readers on Mendeley
See more details